You have 9 free searches left this month | for more free features.

Sq-NSCLC

Showing 1 - 25 of 3,586

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Squamous NSCLC Trial in Jinan ("Envafolimab" and "Chemotherapy" and "Recombinant Human Endostatin")

Recruiting
  • Squamous Non-small Cell Lung Cancer
  • "Envafolimab" and "Chemotherapy" and "Recombinant Human Endostatin"
  • Jinan, Shandong, China
  • +1 more
Feb 14, 2022

Non Small Cell Lung Cancer Trial in Spain (Tipifarnib)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Santiago De Compostela, A Coruña, Spain
  • +29 more
Sep 21, 2022

NSCLC Trial in Worldwide (Nivolumab)

Completed
  • Non-Small Cell Lung Cancer
  • Wels, Oberösterreich, Austria
  • +89 more
Oct 17, 2022

Advanced Solid Tumors Trial in Australia, China (Sitravatinib)

Completed
  • Advanced Solid Tumors
  • Blacktown, New South Wales, Australia
  • +16 more
Jan 10, 2023

NSCLC Trial in Worldwide (RO7247669, Pembrolizumab, Paclitaxel)

Recruiting
  • Non-small Cell Lung Cancer
  • Benowa, Queensland, Australia
  • +6 more
Mar 16, 2023

Squamous NSCLC, Non-squamous NSCLC Trial in Brazil, Canada (Nivolumab)

No longer available
  • Squamous Non-Small Cell Lung Cancer
  • Non-squamous Non-Small Cell Lung Cancer
  • Salvador, Bahia, Brazil
  • +49 more
Nov 25, 2020

Lung Non-Small Cell Squamous Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United States (Berzosertib, Carboplatin,

Recruiting
  • Lung Non-Small Cell Squamous Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Los Angeles, California
  • +34 more
Jan 20, 2023

NSCLC, Non-Small Cell Lung Carcinoma, NSCLC Trial run by the National Cancer Institute (NCI) (biological, drug, device)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Montanide (Registered Trademark) ISA-51 VG Adjuvant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Monitor Lung Cancer Patients Activity And Assess Performance

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Actigraphy device (wearable) and mobile application
  • Alcorcon, Madrid, Spain
  • +10 more
Jan 13, 2023

Non Small Cell Lung Cancer Trial in Tampa, Houston (quaratusugene ozeplasmid, pembrolizumab, docetaxel)

Recruiting
  • Non Small Cell Lung Cancer
  • quaratusugene ozeplasmid
  • +3 more
  • Tampa, Florida
  • +2 more
Sep 12, 2022

Lung Cancer Trial in Worldwide (Nivolumab)

Completed
  • Lung Cancer
  • Nivolumab
  • Birmingham, Alabama
  • +118 more
Mar 11, 2022

Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in United States (SGN-B7H4V)

Recruiting
  • Ovarian Neoplasms
  • +9 more
  • Aurora, Colorado
  • +6 more
Aug 15, 2022

Burns Trial in Riyadh (Enoxaparin 40 mg q24 hours, Enoxaparin 30 mg q12 hours, Unfractionated heparin 5000 U q8 hours)

Completed
  • Burns
  • Enoxaparin 40 mg q24 hours
  • +2 more
  • Riyadh, Saudi Arabia
    King Abdulaziz Medical City
Dec 17, 2022

Rhinitis, Allergic, Seasonal Trial in Lund, Stockholm (ALK Diluent, ALK Alutard SQ 5-grasses or ALK Alutard Birch)

Completed
  • Rhinitis, Allergic, Seasonal
  • ALK Diluent
  • ALK Alutard SQ 5-grasses or ALK Alutard Birch
  • Lund, Sweden
  • +1 more
Jun 22, 2022

Non Small Cell Lung Cancer Squamous (NSCLC-Sq), Head and Neck Squamous Cell Carcinoma (HNSCC), Small Cell Lung Cancer (SCLC)

Completed
  • Non Small Cell Lung Cancer Squamous (NSCLC-Sq)
  • +5 more
  • Huntersville, North Carolina
  • +2 more
Dec 27, 2019

SQ Sublingual Immunotherapy-Tablets vs. Controls in Allergic

Active, not recruiting
  • Allergy
  • +2 more
  • SQ SLIT-tablet
  • Hørsholm, Copenhagen, Denmark
    ALK
Jul 25, 2022

Healthy Trial in Cypress (CD388 Injection, Saline )

Recruiting
  • Healthy
  • CD388 Injection
  • Saline placebo
  • Cypress, California
    Altasciences Clinical Los Angeles, Inc.
Jan 18, 2023

Yellow Fever Vaccination Reaction Trial in Frederick (Yellow Fever Vaccine)

Active, not recruiting
  • Yellow Fever Vaccination Reaction
  • Yellow Fever Vaccine
  • Frederick, Maryland
    United States Army Medical Research Institute of Infectious Dise
May 17, 2022

Healthy Women, Female Contraception Trial in United States (levonorgestrel butanoate (LB) injection)

Recruiting
  • Healthy Women
  • Female Contraception
  • levonorgestrel butanoate (LB) injection
  • Davis, California
  • +6 more
Jan 31, 2022

S-ICD® System Post Approval Study

Completed
  • Primary Prevention of Sudden Cardiac Arrest
  • Secondary Prevention of Sudden Cardiac Arrest
  • S-ICD System
  • Huntsville, Alabama
  • +86 more
May 16, 2022

Lung Cancer Trial (Sacituzumab Govitecan, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • (no location specified)
Sep 20, 2023

Advanced Lung Adenocarcinoma Trial (TCM Formula, Placebo)

Completed
  • Advanced Lung Adenocarcinoma
  • TCM Formula
  • Placebo
  • (no location specified)
Jan 9, 2022

Using Urine Samples to Identify Lung Cancer

Recruiting
  • Non Small Cell Lung Cancer
  • urine sample
  • Basking Ridge, New Jersey
  • +6 more
Sep 5, 2023

NSCLC, NSCLC, PD-1 Trial in Beijing (F520, Pemetrexed, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Feb 22, 2023

Functional Mitral Regurgitation Trial in Shenyang (SQ-Kyrin Transcatheter Mitral Valve Repair System)

Active, not recruiting
  • Functional Mitral Regurgitation
  • SQ-Kyrin Transcatheter Mitral Valve Repair System
  • Shenyang, Liaoning, China
    General Hospital of Northern Theater Command, PLA
Aug 4, 2023